home / stock / rcus / rcus short
Short Information | Arcus Biosciences Inc. (NYSE:RCUS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 26,764 |
Total Actual Volume | 16,099,171 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,338 |
Average Short Percentage | 0.24% |
Is there a RCUS Short Squeeze or Breakout about to happen?
See the RCUS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $14.81 | $14.28 | $15.0695 | $14.13 | 488,865 | 1,508 | 0.31% |
07-18-2024 | $15.4 | $14.73 | $15.67 | $14.69 | 478,324 | 624 | 0.13% |
07-17-2024 | $15.74 | $15.48 | $16.15 | $15.41 | 500,680 | 1,312 | 0.26% |
07-16-2024 | $15.59 | $15.89 | $16.15 | $15.55 | 564,160 | 572 | 0.1% |
07-15-2024 | $15.2 | $15.42 | $15.53 | $15.1 | 405,042 | 158 | 0.04% |
07-12-2024 | $15.17 | $15.11 | $15.46 | $14.81 | 418,545 | 510 | 0.12% |
07-11-2024 | $14.37 | $14.92 | $15.32 | $14.2 | 681,314 | 3,590 | 0.53% |
07-10-2024 | $14.13 | $13.94 | $14.3 | $13.61 | 739,929 | 1,722 | 0.23% |
07-09-2024 | $13.7 | $14.08 | $14.15 | $13.57 | 323,290 | 1,985 | 0.61% |
07-08-2024 | $14.19 | $13.84 | $14.43 | $13.76 | 635,327 | 2,235 | 0.35% |
07-05-2024 | $13.87 | $14.12 | $14.35 | $13.61 | 871,581 | 1,008 | 0.12% |
07-03-2024 | $14.82 | $14.36 | $15.04 | $14.34 | 188,509 | 1,095 | 0.58% |
07-02-2024 | $15.32 | $14.65 | $15.34 | $14.25 | 725,691 | 5,938 | 0.82% |
07-01-2024 | $15.19 | $15.3 | $15.47 | $14.97 | 410,812 | 485 | 0.12% |
06-28-2024 | $15.32 | $15.23 | $15.42 | $14.75 | 2,219,809 | 657 | 0.03% |
06-27-2024 | $15.16 | $15.17 | $15.34 | $14.75 | 651,759 | 679 | 0.1% |
06-26-2024 | $15.7 | $15.16 | $15.87 | $15.16 | 586,528 | 592 | 0.1% |
06-25-2024 | $16.32 | $15.83 | $16.42 | $15.53 | 921,978 | 681 | 0.07% |
06-24-2024 | $16.5 | $16.41 | $16.78 | $16.17 | 541,663 | 836 | 0.15% |
06-21-2024 | $16.42 | $16.35 | $16.815 | $16.01 | 3,745,365 | 577 | 0.02% |
News, Short Squeeze, Breakout and More Instantly...
Arcus Biosciences Inc. Company Name:
RCUS Stock Symbol:
NYSE Market:
Arcus Biosciences Inc. Website:
Arcus Biosciences, Inc. (NYSE:RCUS) and Taiho Pharmaceutical Co., Ltd. (“Taiho”) today announced that Taiho exercised its option for quemliclustat (International Nonproprietary Name; development code: AB680), an investigational small molecule CD73 inhibitor, in Japan and certain oth...
Domvanalimab is the only anti-TIGIT antibody in Phase 3 for upper gastrointestinal (GI) adenocarcinomas with the potential to be first-to-market for this patient population Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing di...
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the upcoming Goldman Sachs 45 th Annual ...